ALB - Public offerings

CHARLOTTE, N.C., May 1, 2024 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2024. First-Quarter 2024 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.4 billion, driven by Energy Storage volume growth as projects rampNet income of $2 million, or ($0.08)(a) per diluted share attributable to common shareholdersAdjusted diluted EPS attributable t

CHARLOTTE, N.C., March 6, 2024 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB) ("Albemarle" or the "Company"), a global leader in providing essential elements for mobility, energy, connectivity, and health, announced that it has priced its previously announced offering (the "Offering") of 40,000,000 depositary shares ("Depositary Shares"), each representing a 1/20th interest in a share of Series A Mandatory Convertible Preferred Stock of the Company ("Preferred Stock"), at a public offering price of $50 per share, in an underwritten registered public offering. In addition, Albemarle granted the underwriters in the Offering a 30-day option to purchase up to an additional 6,000,000 Depositary

CHARLOTTE, N.C., March 4, 2024 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB) ("Albemarle" or the "Company"), a global leader in providing essential elements for mobility, energy, connectivity, and health, today announced that, subject to market and other conditions, it has commenced an offering (the "Offering") of $1.75 billion of depositary shares ("Depositary Shares"), each representing a 1/20th interest in a share of Series A Mandatory Convertible Preferred Stock of the Company ("Preferred Stock"), in an underwritten registered public offering. In addition, Albemarle expects to grant the underwriters in the Offering a 30-day option to purchase up to an additional $262.5 million of Depo

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia and SYDNEY, Australia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Patriot Battery Metals Inc. (the "Company" or "Patriot") ((TSX.V: PMET, ASX: PMT, OTCQX:PMETF, FSE: R9GA)) is pleased to announce that it has closed its previously announced private placement of approximately C$109 million (the "Strategic Investment") in Patriot by Albemarle Corporation ("Albemarle") (NYSE:ALB). Following closing of the Strategic Investment, Albemarle now owns approximately 4.9% of Patriot's issued and outstanding Common Shares on a fully-diluted in-the-money basis, or 6.4% on a

CHARLOTTE, N.C., May 11, 2022 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a leader in the global specialty chemicals industry, today announced the pricing of an underwritten public offering of senior notes consisting of: $650,000,000 of 4.650% senior notes due 2027,$600,000,000 of 5.050% senior notes due 2032, and$450,000,000 of 5.650% senior notes due 2052.The notes will be Albemarle's general senior unsecured obligations. The gross proceeds from the offering are expected to be approximately $1.7 billion, before deducting the underwriting discounts and commissions and e

CHARLOTTE, N.C., Feb. 3, 2021 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced the pricing of a previously announced underwritten public offering of 8,496,733 shares of its common stock at a price to the public of $153.00 per share. The gross proceeds from this offering are expected to be approximately $1.3 billion, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Albemarle. Albemarle has granted the underwriters a 30-day option to purchase up to 1,274,509 additional shares at the public offering price, less the underwriting discounts and commissions. The offering i

CHARLOTTE, N.C., Feb. 2, 2021 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced that it has commenced an underwritten public offering of $1,300,000,000 of shares of its common stock. In connection with this offering, Albemarle expects to grant the underwriters a 30-day option to purchase up to $195,000,000 of additional shares at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Albemarle intends to use the